Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics With Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks

NCT04907409 is registered in ClinicalTrials.gov with Notal Vision Inc. as lead sponsor.

NCT NCT04907409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics With Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks
Lead sponsor
Notal Vision Inc.
Phase
Observational
Overall status
Unknown status
Start date
June 17, 2021
Completion date
August 30, 2022
Enrollment
120 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration